Original Research
Published on 29 Aug 2023
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein
in Virology
![The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein](https://www.frontiersin.org/files/myhome article library/1206951/1206951_Thumb_400.jpg)
- 2,517 views
- 1 citation
Original Research
Published on 29 Aug 2023
in Virology
Original Research
Published on 25 Aug 2023
in Virology
Editorial
Published on 25 Aug 2023
in Virology
Original Research
Published on 23 Aug 2023
in Virology
Original Research
Published on 22 Aug 2023
in Virology
Mini Review
Published on 21 Aug 2023
in Virology
Original Research
Published on 17 Aug 2023
in Virology
Review
Published on 14 Aug 2023
in Virology
Original Research
Published on 14 Aug 2023
in Virology
Review
Published on 14 Aug 2023
in Virology
Original Research
Published on 11 Aug 2023
in Virology
Original Research
Published on 10 Aug 2023
in Virology
Original Research
Published on 09 Aug 2023
in Virology
Original Research
Published on 08 Aug 2023
in Virology
Review
Published on 07 Aug 2023
in Virology
Review
Published on 07 Aug 2023
in Virology